Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 68 entries
View as:

Pilot Pharmacokinetic Study of New Nicotine Lozenge Formulations

Phase: N/A Priority: Normal
NCT ID: NCT01574898 Org: User:
Start: 03/31/12 End: 06/30/12 Due: 06/30/13

CLEARI (Clinical Efficacy Assessment on Recurrent Upper-Respiratory Tract Infections) Study

Phase: N/A Priority: Normal
NCT ID: NCT01948856 Org: User:
Start: 09/30/13 End: 12/13/16 Due: 12/13/17

A Study to Evaluate KIN-2787 in Participants with BRAF And/or NRAS Mutation Positive Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04913285 Org: User:
Start: 08/04/21 End: 03/30/29 Due: 03/30/30

Effect of F2695 on Functional Recovery After Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT01639014 Org: User:
Start: 07/31/12 End: 02/28/15 Due: 02/28/16

Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00683514 Org: User:
Start: 04/30/05 End: - Due: -

Effect of V0251 in Acute Vertigo

Phase: N/A Priority: Normal
NCT ID: NCT01583738 Org: User:
Start: 04/30/12 End: 04/30/13 Due: 04/30/14

Evaluation and Comparison of Systemic Exposure to Ibuprofen After Single Oromucosal Versus Oral Administrations

Phase: N/A Priority: Normal
NCT ID: NCT01859377 Org: User:
Start: 05/31/13 End: 06/30/13 Due: 06/30/14

Exploratory Study in the Relief of Drug-induced Xerostomia Associated With Hyposialia

Phase: N/A Priority: Normal
NCT ID: NCT02005328 Org: User:
Start: 12/31/13 End: 02/28/14 Due: 02/28/15

Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05003622 Org: User:
Start: 09/27/21 End: 05/06/22 Due: 05/06/23

Safety, Preliminary Pharmacokinetics and Bronchodilator Properties of V0162

Phase: N/A Priority: Normal
NCT ID: NCT01348555 Org: User:
Start: 04/30/11 End: 07/31/12 Due: 07/31/13

Acute Sore Throat Pain Study

Phase: N/A Priority: Normal
NCT ID: NCT01535079 Org: User:
Start: 02/29/12 End: 11/30/12 Due: 11/30/13

Relative Bioavailability of Binimetinib 3 x 15 mg and 45 mg Formulations

Phase: N/A Priority: Normal
NCT ID: NCT05103891 Org: User:
Start: 09/03/21 End: 11/29/21 Due: 11/29/22

Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia

Phase: N/A Priority: Normal
NCT ID: NCT01757119 Org: User:
Start: 01/31/13 End: 03/31/14 Due: 03/31/15

Treatment Patterns of Neratinib in HER2+ EBC in China

Phase: N/A Priority: Normal
NCT ID: NCT05491057 Org: User:
Start: 09/30/22 End: 06/30/26 Due: 06/30/27

Nicotine Patch Safety Study

Phase: N/A Priority: Normal
NCT ID: NCT01655082 Org: User:
Start: 08/31/12 End: 10/31/12 Due: 10/31/13

Bronchodilator Properties and Safety in Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01951222 Org: User:
Start: 09/30/13 End: 04/30/14 Due: 04/30/15

JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin

Phase: N/A Priority: Normal
NCT ID: NCT01599013 Org: User:
Start: 02/28/11 End: 04/30/14 Due: 04/30/15

EXPLORATORY ASSESSMENT OF THE EFFECTS OF CYCLO 3 ® FORT (Ruscus Extract, Hesperidin Methyl Chalcone, Ascorbic Acid) OR MICRONISED PURIFIED FLAVONOID FRACTION ON VASCULAR PARAMETERS AND BIOMARKERS IN WOMEN SUFFERING FROM CHRONIC VENOUS DISEASE (CEAP C2 OR C3), OVER 8 WEEKS

Phase: N/A Priority: Normal
NCT ID: NCT02907320 Org: User:
Start: 12/31/16 End: 05/31/18 Due: 05/31/19

Efficacy on Volume Reduction and Tolerance of Progressiv' Medical Compressive Therapy (MCT) V0322 BC in Patients With Chronic Venous Oedema

Phase: N/A Priority: Normal
NCT ID: NCT01402921 Org: User:
Start: 01/31/11 End: 03/31/12 Due: 03/31/13

Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03887130 Org: User:
Start: 03/27/07 End: 04/18/13 Due: 04/18/14

FMS European Long-Term Study

Phase: N/A Priority: Normal
NCT ID: NCT00757731 Org: User:
Start: 09/30/06 End: 10/31/08 Due: 10/31/09

An Observational Real-world Study to Evaluate the Impact of Dermatological Toxicities on the Quality of Life in Patients With Early Breast Cancer Treated With Adjuvant Endocrine Therapy - BCARE (Breast Cancer Adjuvant Real-world Evaluation of Dermatological Adverse Events)

Phase: N/A Priority: Normal
NCT ID: NCT06690489 Org: User:
Start: 11/22/24 End: 03/31/26 Due: 03/31/27

Oral Vinorelbine as Induction Chemotherapy Followed Concomitant Chemoradiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01839032 Org: User:
Start: 05/31/05 End: 10/31/08 Due: 10/31/09

First-In-Human (FIH) Study of W0180 as Single Agent and in Combination With Pembrolizumab in Adults With Locally Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04564417 Org: User:
Start: 09/08/20 End: 12/19/23 Due: 12/19/24

Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01095003 Org: User:
Start: 05/31/09 End: 10/31/15 Due: 10/31/16